Literature DB >> 28935038

Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation.

Lei Song1, Lai Wang1, Fuqiang Li1, Ada Yukht1, Minghui Qin1, Haley Ruther1, Mingjie Yang1, Aurelio Chaux1, Prediman K Shah1, Behrooz G Sharifi2.   

Abstract

BACKGROUND: Tenascin-C (TNC) is a highly conserved matricellular protein with a distinct expression pattern during development and disease. Remodeling of the left ventricle (LV) in response to pressure overload leads to the re-expression of the fetal gene program.
OBJECTIVES: The aim of this study was to investigate the function of TNC in cardiac hypertrophy in response to pressure overload.
METHODS: Pressure overload was induced in TNC knockout and wild-type mice by constricting their abdominal aorta or by infusion of angiotensin II. Echocardiography, immunostaining, flow cytometry, quantitative real-time polymerase chain reaction, and reciprocal bone marrow transplantation were used to evaluate the effect of TNC deficiency.
RESULTS: Echocardiographic analysis of pressure overloaded hearts revealed that all LV parameters (LV end-diastolic and -systolic dimensions, ejection fraction, and fractional shortening) deteriorated in TNC-deficient mice compared with their wild-type counterparts. Cardiomyocyte size and collagen accumulation were significantly greater in the absence of TNC. Mechanistically, TNC deficiency promoted rapid accumulation of the CCR2+/Ly6Chi monocyte/macrophage subset into the myocardium in response to pressure overload. Further, echocardiographic and immunohistochemical analyses of recipient hearts showed that expression of TNC in the bone marrow, but not the myocardium, protected the myocardium against excessive remodeling of the pressure-overloaded heart.
CONCLUSIONS: TNC deficiency further impaired cardiac function in response to pressure overload and exacerbated fibrosis by enhancing inflammation. In addition, expression of TNC in the bone marrow, but not the myocardium, protected the myocardium against excessive remodeling in response to mild pressure overload.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  left ventricle; macrophage; pressure overload; tenascin

Mesh:

Substances:

Year:  2017        PMID: 28935038      PMCID: PMC5678983          DOI: 10.1016/j.jacc.2017.07.789

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  65 in total

1.  Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells.

Authors:  Ying Li; Dale A Kinzenbaw; Mary L Modrick; Lecia L Pewe; Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

2.  Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload.

Authors:  S Izumo; B Nadal-Ginard; V Mahdavi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.

Authors:  Antony Vinh; Wei Chen; Yelena Blinder; Daiana Weiss; W Robert Taylor; Jörg J Goronzy; Cornelia M Weyand; David G Harrison; Tomasz J Guzik
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

4.  Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.

Authors:  Kiyohito Yamamoto; Koji Onoda; Yasuhiro Sawada; Kazuya Fujinaga; Kyoko Imanaka-Yoshida; Hideto Shimpo; Toshimichi Yoshida; Isao Yada
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

5.  Bioengineered vascular graft grown in the mouse peritoneal cavity.

Authors:  Lei Song; Lai Wang; Prediman K Shah; Aurelio Chaux; Behrooz G Sharifi
Journal:  J Vasc Surg       Date:  2010-08-08       Impact factor: 4.268

Review 6.  Tenascin-C in cardiovascular tissue remodeling: from development to inflammation and repair.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Circ J       Date:  2012-10-13       Impact factor: 2.993

7.  Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis.

Authors:  Stephanie Schulte; Galina K Sukhova; Peter Libby
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

8.  Tenascin knockout mice: barrels, boundary molecules, and glial scars.

Authors:  D A Steindler; D Settles; H P Erickson; E D Laywell; A Yoshiki; A Faissner; M Kusakabe
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

9.  The distribution of fibronectin and tenascin along migratory pathways of the neural crest in the trunk of amphibian embryos.

Authors:  H H Epperlein; W Halfter; R P Tucker
Journal:  Development       Date:  1988-08       Impact factor: 6.868

10.  Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth.

Authors:  P L Jones; J Crack; M Rabinovitch
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

View more
  16 in total

1.  Deficiency of GATA3-Positive Macrophages Improves Cardiac Function Following Myocardial Infarction or Pressure Overload Hypertrophy.

Authors:  Mingjie Yang; Lei Song; Lai Wang; Ada Yukht; Haley Ruther; Fuqiang Li; Minghui Qin; Homayon Ghiasi; Behrooz G Sharifi; Prediman K Shah
Journal:  J Am Coll Cardiol       Date:  2018-08-21       Impact factor: 24.094

Review 2.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

3.  Intermedin1-53 Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis.

Authors:  Lin-Shuang Zhang; Jin-Sheng Zhang; Yue-Long Hou; Wei-Wei Lu; Xian-Qiang Ni; Fan Lin; Xiu-Ying Liu; Xiu-Jie Wang; Yan-Rong Yu; Mo-Zhi Jia; Chao-Shu Tang; Ling Han; San-Bao Chai; Yong-Fen Qi
Journal:  Inflammation       Date:  2022-02-17       Impact factor: 4.092

Review 4.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

5.  Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta.

Authors:  Kyoko Imanaka-Yoshida; Ken-Ichi Matsumoto
Journal:  Ann Vasc Dis       Date:  2018-06-25

6.  Protective mechanism of SIRT1 on Hcy-induced atrial fibrosis mediated by TRPC3.

Authors:  Lu Han; Yanhua Tang; Shaochuan Li; Yanqing Wu; Xiaoshu Chen; Qinghua Wu; Kui Hong; Juxiang Li
Journal:  J Cell Mol Med       Date:  2019-11-04       Impact factor: 5.310

Review 7.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

8.  Adaptation within embryonic and neonatal heart environment reveals alternative fates for adult c-kit+ cardiac interstitial cells.

Authors:  Bingyan J Wang; Roberto Alvarez; Alvin Muliono; Sharon Sengphanith; Megan M Monsanto; Joi Weeks; Roberto Sacripanti; Mark A Sussman
Journal:  Stem Cells Transl Med       Date:  2019-12-31       Impact factor: 6.940

Review 9.  Morphological and Functional Characteristics of Animal Models of Myocardial Fibrosis Induced by Pressure Overload.

Authors:  Yuejia Ding; Yuan Wang; Qiujin Jia; Xiaoling Wang; Yanmin Lu; Ao Zhang; Shichao Lv; Junping Zhang
Journal:  Int J Hypertens       Date:  2020-01-31       Impact factor: 2.420

Review 10.  The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis.

Authors:  Michael Chute; Preetinder Aujla; Sayantan Jana; Zamaneh Kassiri
Journal:  J Cardiovasc Dev Dis       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.